Stocks Overview

LAST PRICE
59.5200
TODAY'S CHANGE (%)
Trending Up0.4700 (0.7959%)

Bid / Lots
59.3500/ 21
Ask / Lots
59.5800/ 4
Open / Previous Close
59.6600 / 59.0500
Day Range
Low 58.7600
High 60.9000
52 Week Range
Low 42.2100
High 76.9800
Volume
279,868
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 59.025
Time	Volume	IMCR
09:32 ET	4025	59.795
09:38 ET	425	59.25
09:39 ET	500	59.057
09:41 ET	3620	58.87
09:50 ET	3300	59
09:52 ET	114	59
09:54 ET	777	59.11
09:57 ET	1203	59.08
09:59 ET	200	59.02
10:01 ET	300	59.06
10:03 ET	200	59.02
10:06 ET	300	59.06
10:08 ET	1100	58.89
10:10 ET	200	58.825
10:12 ET	500	58.88
10:15 ET	800	59
10:17 ET	25100	58.91
10:19 ET	900	58.89
10:26 ET	1003	59
10:28 ET	400	59
10:30 ET	600	59
10:32 ET	662	59
10:33 ET	2500	59
10:35 ET	6362	59.2
10:37 ET	200	59.385
10:42 ET	100	59.41
10:44 ET	100	59.42
10:46 ET	700	59.69
10:48 ET	300	59.38
10:51 ET	400	59.515
10:53 ET	600	59.51
10:55 ET	863	59.47
10:57 ET	100	59.5
11:00 ET	100	59.48
11:02 ET	200	59.47
11:04 ET	100	59.465
11:06 ET	300	59.46
11:08 ET	100	59.455
11:09 ET	657	59.32
11:11 ET	200	59.305
11:13 ET	950	59.22
11:15 ET	100	59.22
11:22 ET	600	59.22
11:24 ET	100	59.31
11:26 ET	840	59.22
11:27 ET	200	59.305
11:29 ET	1279	59.24
11:31 ET	200	59.305
11:33 ET	1419	59.27
11:36 ET	1859	59.19
11:38 ET	1389	59.13
11:42 ET	1400	59.13
11:44 ET	100	59.17
11:45 ET	300	59.23
11:47 ET	100	59.26
11:49 ET	100	59.27
11:51 ET	528	59.23
11:56 ET	11463	59.31
11:58 ET	400	59.25
12:00 ET	100	59.31
12:02 ET	500	59.36
12:03 ET	500	59.31
12:05 ET	300	59.325
12:07 ET	7419	59.18
12:09 ET	7911	59.24
12:12 ET	1423	59.41
12:14 ET	2350	59.23
12:16 ET	423	59.26
12:18 ET	100	59.29
12:20 ET	27700	59.2675
12:21 ET	24485	59.29
12:23 ET	21563	59.35
12:25 ET	3384	59.62
12:27 ET	1600	59.66
12:30 ET	1100	59.58
12:32 ET	100	59.65
12:34 ET	100	59.64
12:36 ET	960	59.625
12:38 ET	757	59.55
12:41 ET	650	59.66
12:43 ET	303	59.62
12:45 ET	300	59.65
12:48 ET	300	59.78
12:50 ET	1239	59.55
12:52 ET	333	59.63
12:56 ET	100	59.625
12:57 ET	1123	59.475
12:59 ET	100	59.27
01:01 ET	100	59.29
01:08 ET	500	59.435
01:10 ET	1305	59.32
01:12 ET	500	59.45
01:14 ET	100	59.5
01:15 ET	200	59.5
01:17 ET	331	59.43
01:19 ET	100	59.45
01:21 ET	6221	59.2
01:24 ET	100	59.2
01:28 ET	1400	59.22
01:30 ET	3960	59.25
01:32 ET	200	59.28
01:33 ET	300	59.345
01:37 ET	300	59.335
01:39 ET	600	59.335
01:42 ET	1600	59.185
01:46 ET	1100	59.185
01:48 ET	3200	59.37
01:50 ET	1200	59.575
01:51 ET	1000	59.635
01:53 ET	100	59.68
01:55 ET	547	59.59
02:00 ET	2000	59.57
02:02 ET	100	59.53
02:04 ET	1281	59.5
02:09 ET	100	59.59
02:11 ET	1200	59.62
02:13 ET	200	59.63
02:15 ET	300	59.58
02:18 ET	700	59.58
02:20 ET	500	59.63
02:22 ET	400	59.58
02:24 ET	200	59.58
02:26 ET	300	59.63
02:27 ET	200	59.58
02:29 ET	1200	59.46
02:31 ET	200	59.47
02:33 ET	500	59.47
02:38 ET	1900	59.31
02:42 ET	200	59.39
02:44 ET	100	59.385
02:45 ET	300	59.405
02:47 ET	500	59.405
02:49 ET	300	59.405
02:51 ET	100	59.45
02:54 ET	300	59.45
02:56 ET	3400	59.31
02:58 ET	100	59.31
03:00 ET	1500	59.33
03:02 ET	929	59.33
03:03 ET	800	59.3
03:05 ET	400	59.305
03:07 ET	1100	59.47
03:09 ET	400	59.47
03:12 ET	200	59.58
03:14 ET	516	59.47
03:16 ET	100	59.52
03:18 ET	100	59.52
03:20 ET	100	59.52
03:21 ET	100	59.52
03:23 ET	100	59.52
03:25 ET	1300	59.52
03:27 ET	300	59.52

Data delayed at least 15 minutes.

Apr 29, 2024
- DJ Immunocore Holdings Initiated at Outperform by Leerink Partners, from 9:11AM ET on Monday Apr 29, 2024 by Dow Jones
  9:11AM ET on Monday Apr 29, 2024 by Dow Jones
Apr 24, 2024
- Immunocore announces upcoming presentation and posters at ASCO 2024, from 10:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
  10:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 23, 2024
- DJ Immunocore Holdings Price Target Maintained With a $92.00/Share by Guggenheim, from 1:08PM ET on Tuesday Apr 23, 2024 by Dow Jones
  1:08PM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 11, 2024
- DJ Immunocore Holdings Price Target Maintained With a $81.00/Share by Needham, from 6:50AM ET on Thursday Apr 11, 2024 by Dow Jones
  6:50AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 4, 2024
- Immunocore to present at upcoming investor conferences, from 4:00PM ET on Thursday Apr 04, 2024 by Dow Jones
  4:00PM ET on Thursday Apr 04, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesIMCR Immunocore Holdings PLC	3.0B	-52.6x	---
United StatesCORT Corcept Therapeutics Inc	2.5B	26.5x	+9.80%
United StatesLGND Ligand Pharmaceuticals Inc	1.3B	24.8x	-12.71%
United StatesINVA Innoviva Inc	952.2M	6.8x	-9.89%
United StatesAVDL Avadel Pharmaceuticals PLC	1.8B	-9.0x	---
United StatesEOLS Evolus Inc	774.5M	-12.2x	---
As of 2024-05-02

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters: 90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone: 123-543-8600
Fax: ---

Executives

Independent Chairman of the Board: John Bell
Chief Executive Officer, Director: Bahija Jallal
Chief Financial Officer, Head of Strategy: Brian Di Donato
Chief Human Resource Officer: Tina St Leger
Head of Research and Development: David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.0B
Revenue (TTM)	$249.4M
Shares Outstanding	50.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	$-1.13
Book Value	$7.42
P/E Ratio	-52.6x
Price/Sales (TTM)	11.8
Price/Cash Flow (TTM)	---
Operating Margin	-23.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Immunocore Holdings PLC
NASDAQ:IMCRUnited States

Search Criteria

Charts

Recent News

Apr 29, 2024

DJ Immunocore Holdings Initiated at Outperform by Leerink Partners, from 9:11AM ET on Monday Apr 29, 2024 by Dow Jones

Apr 24, 2024

Immunocore announces upcoming presentation and posters at ASCO 2024, from 10:00AM ET on Wednesday Apr 24, 2024 by Dow Jones

Apr 23, 2024

DJ Immunocore Holdings Price Target Maintained With a $92.00/Share by Guggenheim, from 1:08PM ET on Tuesday Apr 23, 2024 by Dow Jones

Apr 11, 2024

DJ Immunocore Holdings Price Target Maintained With a $81.00/Share by Needham, from 6:50AM ET on Thursday Apr 11, 2024 by Dow Jones

Apr 4, 2024

Immunocore to present at upcoming investor conferences, from 4:00PM ET on Thursday Apr 04, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar